Connective tissue growth factor (CTGF) promotes activated mesangial cell survival via up-regulation of mitogen-activated protein kinase phosphatase-1 (MKP-1)

Biochemical Journal

Volumn 406, Issue 1, 2007, Pages 131-138

  Wahab, Nadia ^a   Cox, Dimity ^a   Witherden, Abigail ^a   Mason, Roger M ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Cell survival; Connective tissue growth factor (CTGF); Diabetic nephropathy (DN); Mesangial cell; Mitogen activated protein kinase (MAPK) phosphatase 1 (MKP 1)

Indexed keywords

ENZYMES; GROWTH KINETICS; RNA; TISSUE; TRANSCRIPTION;

CONNECTIVE TISSUE GROWTH FACTOR (CTGF); DIABETIC NEPHROPATHY (DN); MESANGIAL CELL; PATHOGENESIS;

CELLS;

ANTISENSE OLIGODEOXYNUCLEOTIDE; CONNECTIVE TISSUE GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; PROTEIN BCL 2; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; CELL CYCLE PROTEIN; DUAL SPECIFICITY PHOSPHATASE 1; IMMEDIATE EARLY PROTEIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL SURVIVAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; UPREGULATION; ADULT; BIOLOGICAL MODEL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADULT; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MESANGIAL CELLS; MODELS, BIOLOGICAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 34547850679     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20061817     Document Type: Article

References (42)

1. Johnson, R., Floege, J., Yoshimura, A., Iida, H., Couser, W. and Alpers, C. (1992) The activated mesangial cell: a glomerular 'myofibroblast'? J. Am. Soc. Nephrol. 2, S190-S197
2. Desmouliere, A., Redard, M., Darby, I. and Gabbiani, G. (1995) Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 146, 56-66
3. Enzan, H. (1985) Proliferation of Ito cells (fat-storing cells) in acute carbon tetrachloride liver injury. A light and electron microscopic autoradiographic study. Acta Pathol. Japan. 35, 1301-1308
4. Park, S.-K., Kim, J.-a., Seomun, Y., Choi, J., Kim, D.-H., Han, I.-O., Lee, E. H., Chung, S.-K. and Joo, C.-K. (2001) Hydrogen peroxide is a novel inducer of connective tissue growth factor. Biochem. Biophys. Res. Commun. 284, 966-971
5. Higgins, D. F., Biju, M. P., Akai, Y., Wutz, A., Johnson, R. S. and Haase, V. H. (2004) Hypoxic induction of CTGF is directly mediated by Hif-1. Am. J. Physiol. Renal. Physiol. 287, F1223-F1232
6. Mason, R. M. and Wahab, N. A. (2003) Extracellular matrix metabolism in diabetic nephropathy. J. Am. Soc. Nephrol. 14, 1358-1373
7. Abdel Wahab, N. and Mason, R. M. (2004) Connective tissue growth factor and renal diseases: some answers, more questions. Curr. Opin. Nephrol. Hypertens. 13, 53-58
8. Abdel-Wahab, N., Weston, B. S., Roberts, T. and Mason, R. M. (2002) Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy. J. Am. Soc. Nephrol. 13, 2437-2445
9. Wahab, N. A., Yevdokimova, N., Weston, B. S., Roberts, T., Li, X., Brinkman, H. and Mason, R. M. (2001) Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem. J. 359, 77-87
10. Weston, B. S., Wahab, N. A. and Mason, R. M. (2003) CTGF mediates TGF-β-induced fibronectin matrix deposition by upregulating active α5β1 integrin in human mesangial cells. J. Am. Soc. Nephrol. 14, 601-610
11. Wahab, N. A., Weston, B. S. and Mason, R. M. (2005) Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA. J. Am. Soc. Nephrol. 16, 340-351
12. Garrington, T. P. and Johnson, G. L. (1999) Organization and regulation of mitogen-activated protein kinase signalling pathways. Curr. Opin. Cell Biol. 11, 211-218
13. Franklin, C. C. and Kraft, A. S. (1997) Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J. Biol. Chem. 272, 16917-16923
14. Hutter, D., Chen, P., Barnes, J. and Liu, Y. (2000) Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation. Biochem. J. 352, 155-163
15. Haldar, S., Chintapalli, J. and Croce, C. (1996) Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56, 1253-1255
16. Chadebech, P., Brichese, L., Baldin, V., Vidal, S. and Valette, A. (1999) Phosphorylation and proteasome-dependent degradation of Bcl-2 in mitotic-arrested cells after microtubule damage. Biochem. Biophys. Res. Commun. 262, 823-827
17. Makino, H., Kashihara, N., Sugiyama, H., Kanao, K., Sekikawa, T., Okamoto, K., Maeshima, Y., Ota, Z. and Nagai, R. (1996) Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes. Diabetes 45, 488-495
18. Kishino, M., Kimura, A., Yamaguchi, K., Ohtani, H., Yamada, Y., Takahashi, T., Mune, M., Mimura, K., Maeda, T., Matsumura, S. et al. (1996) Increased expression of a brain/embryo-type myosin heavy chain isoform (MIIB2) in mesangial proliferative glomerulonephritis. Kidney Int. 49, 1350-1359
19. Wahab, N. A., Schaefer, L., Weston, B. S., Yiannikouris, O., Wright, A., Babelova, A., Schaefer, R. and Mason, R. M. (2005) Glomerular expression of thrombospondin-1, transforming growth factor β and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabetologia 48, 2650-2660
20. Kaiser, R. A., Bueno, O. F., Lips, D. J., Doevendans, P. A., Jones, F., Kimball, T. F. and Molkentin, J. D. (2004) Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-repertusion in vivo. J. Biol. Chem. 279, 15524-15530
21. Keyse, S. (1995) An emerging family of dual specificity MAP kinase phosphatases. Biochim. Biophys. Acta 1265, 152-160
22. Duff, J. L. and Monia, B. P. (1995) Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. J. Biol. Chem. 270, 7161-7166
23. Xu, Q., Konta, T. and Kitamura, M. (2002) Retinoic acid regulation of mesangial cell apoptosis. Exp. Nephrol. 10, 171-175
24. Brondello, J.-M., Brunet, A., Pouyssegur, J. and McKenzie, F. R. (1997) The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J. Biol. Chem. 272, 1368-1376
25. Guo, Y., Kang, B. and Williamson, J. (1999) Resistance to TNF-α cytotoxicity can be achieved through different signalling pathways in rat mesangial cells. Am. J. Physiol. 276, C435-C441
26. Peinado-Ramon, P., Wallen, A. and Hallbrook, F. (1998) MAP kinase phosphatase-1 mRNA is expressed in embryonic sympathetic neurons and is upregulated after NGF stimulation. Brain Res. Mol. Brain Res. 56, 256-267
27. Ryser, S., Tortola, S., van Haasteren, G., Muda, M., Li, S. and Schlegel, W. (2001) MAP kinase phosphatase-1 gene transcription in rat neuroendocrine cells is modulated by a calcium-sensitive block to elongation in the first exon. J. Biol. Chem. 276, 33319-33327
28. Pathan, N., Aime-Sempe, C., Kitada, S., Basu, A., Haldar, S. and Reed, J. C. (2001) Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1. Neoplasia 3, 550-559
29. Fan, M., Goodwin, M., Vu, T., Brantley-Finley, C., Gaarde, W. A. and Chambers, T. C. (2000) Vinblastine-induced phosphorylation of Bcl-2 and Bcl-XL is mediated by JNK and occurs in parallel with inactivation of the Raf-1/MEK/ERK Cascade. J. Biol. Chem. 275, 29980-29985
30. Ojala, P. M., Yamamoto, K., Castanos-Velez, E., Biberfeld, P., Korsmeyer, S. J. and Makela, T. P. (2000) The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat. Cell Biol. 2, 819-825
31. Ruvolo, P. P., Deng, X., Carr, B. K. and May, W. S. (1998) A functional role for mitochondrial protein kinase C α in Bcl2 phosphorylation and suppression of apoptosis. J. Biol. Chem. 273, 25436-25442
32. Scacheri, P. C., Rozenblatt-Rosen, O., Caplen, N. J., Wolfsberg, T. G., Umayam, L., Lee, J. C., Hughes, C. M., Shanmugam, K. S., Bhattacharjee, A., Meyerson, M. and Collins, F. S. (2004) Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 101, 1892-1897
33. Chang, B., Minn, A., Muchmore, S., Fesik, S. and Thompson, C. (1997) Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J. 16, 968-977
34. Torcia, M., De Chiara, G., Nencioni, L., Ammendola, S., Labardi, D., Lucibello, M., Rosini, P., Marlier, L. N. J. L., Bonini, P., Sbarba, P. D. et al. (2001) Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release. J. Biol. Chem. 276, 39027-39036
35. Doench, J. G., Petersen, C. P. and Sharp, P. A. (2003) siRNAs can function as miRNAs. Genes Dev. 17, 438-442
36. Snove, J. O. and Holen, T. (2004) Many commonly used siRNAs risk off-target activity. Biochem. Biophys. Res. Commun. 319, 256-263
37. Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A.-L. and Iggo, R. (2003) Induction of an interferon response by RNAi vectors in mammalian cells. Nat. Genet. 34, 263-264
38. Gygi, D., Zumstein, P., Grossenbacher, D., Altwegg, L., Luscher, T. F. and Gehring, H. (2003) Human connective tissue growth factor expressed in Escherichia coli is a non-mitogenic inhibitor of apoptosis. Biochem. Biophys. Res. Commun. 311, 685-690
39. Hishikawa, K., Oemar, B. S., Tanner, F. C., Nakaki, T., Luscher, T. F. and Fujii, T. (1999) Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J. Biol. Chem. 274, 37461-37466
40. Okado, T., Terada, Y., Tanaka, H., Inoshita, S., Nakao, A. and Sasaki, S. (2002) Smad7 mediates transforming growth factors-β-induced apoptosis in mesangial cells. 62, 1178-1186
41. Edlund, S., Bu, S., Schuster, N., Aspenstrom, P., Heuchel, R., Heldin, N.-E., ten Dijke, P., Heldin, C.-H. and Landstrom, M. (2003) Transforming growth factor-β 1 (TGF-β)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-β-activated kinase 1 and mitogen-activated protein kinase kinase 3. Mol. Biol. Cell 14, 529-544
42. Wahab, N. A., Weston, B. S. and Mason, R. M. (2005) Modulation of the TGFβ/Smad signaling pathway in mesangial cells by CTGF/CCN2. Exp. Cell Res. 307, 305-314